In support of the role of PP2A B55α as a tumor suppressor in ovarian cancer 42, 57.14% of ovarian cancer shown PPP2R2A expression reduction due to 41.75% of ovarian cancer samples with PPP2R2A loss of heterozygosity (LOH) 31, 43. This evidence concerns the gene PPP2R2A and ovarian carcinoma.